ERBB2 and breast carcinoma: The reported results represent an initial step towards the development of more effective therapeutic options for cats with mammary carcinoma and interestingly, all assays reveal promising results and a conserved mechanism of action [10,11], by comparison to a human HER2-overexpressing cell line (SKBR-3; American Type Culture Collection [86]).